scholarly journals Costs of Hormonal and Nonhormonal Prescription Medications for Hot Flashes

2009 ◽  
Vol 5 (5) ◽  
pp. 497-502 ◽  
Author(s):  
Amie Williams-Frame ◽  
Janet S Carpenter
Keyword(s):  
Public Health ◽  
Hot Flashes ◽  
Treatment Decisions ◽  
Health Issue ◽  
Public Health Issue ◽  
Prescription Medications ◽  
Cost Information ◽  
Significant Public Health ◽  
The Usa ◽  
Cardinal Symptom

Hot flashes are the cardinal symptom of menopause and can be treated with hormonal and nonhormonal prescription medications. However, considering that 6000 women enter menopause daily in the USA, and many of these women are symptomatic, the costs of these treatments can be a significant public health issue. We evaluated annual individual and population costs of hormonal and nonhormonal prescription treatments for hot flashes. Cost information may be helpful to clinicians and consumers in making treatment decisions.

Identifying changes in trends in the age standardized incidence of melanoma in Australia

2019 ◽  
Vol 3 (4) ◽  
pp. 250-252 ◽  
Author(s):  
David M Hille
Keyword(s):  
Public Health ◽  
Linear Regression ◽  
Iterative Process ◽  
Linear Trend ◽  
Piecewise Linear ◽  
Health Issue ◽  
Public Health Issue ◽  
Piecewise Linear Regression ◽  
Significant Public Health ◽  
Males And Females

ObjectiveTo identify changes in the linear trend of the age-standardized incidence of melanoma in Australia for all persons, males, and females. MethodsA two-piece piecewise linear regression was fitted to the data. The piecewise breakpoint varied through an iterative process to determine the model that best fits the data.ResultsStatistically significant changes in the trendof the age-standardized incidence of melanoma in Australia were found for all persons, males, and females. The optimal breakpoint for all persons and males was at 1998. For females, the optimal breakpoint was at 2005. The trend after these breakpoints was flatter than prior to the breakpoints, but still positive.ConclusionMelanoma is a significant public health issue in Australia. Overall incidence continues to increase. However, the rate at which the incidence is increasing appears to be decreasing.

495: FIREARM INJURIES IN CHILDREN IN THE USA: A PERSISTENT, PERVASIVE, PUBLIC HEALTH ISSUE!

2016 ◽  
Vol 44 (12) ◽  
pp. 200-200
Author(s):  
Veerajalandhar Allareddy ◽  
Sankeerth Rampa ◽  
Romesh Nalliah ◽  
Min Kyeong Lee ◽  
Marcelo Auslender ◽  
...  
Keyword(s):  
Public Health ◽  
Health Issue ◽  
Public Health Issue ◽  
Firearm Injuries ◽  
The Usa

scholarly journals 402 Child injuries in Croatia – significant public health issue

2016 ◽  
Vol 22 (Suppl 2) ◽  
pp. A147.2-A147
Author(s):  
Ivana Brkic Bilos ◽  
Maja Silobrcic Radic ◽  
Verica Kralj ◽  
Tanja Coric
Keyword(s):  
Public Health ◽  
Health Issue ◽  
Public Health Issue ◽  
Child Injuries ◽  
Significant Public Health

A novel case of ocular cicatricial pemphigoid induced by levamisole-adulterated cocaine

2021 ◽  
Vol 31 (1_suppl) ◽  
pp. 11-15
Author(s):  
Chinedu N Igwe ◽  
Fiona Robinson ◽  
Sophie M Jones
Keyword(s):  
Public Health ◽  
Case Report ◽  
Health Issue ◽  
Public Health Issue ◽  
Cicatricial Pemphigoid ◽  
Ocular Manifestation ◽  
Ocular Cicatricial Pemphigoid ◽  
Significant Public Health

Aim: To report a case of ocular cicatricial pemphigoid caused by levamisole-adulterated cocaine. Methods: Case report. Results: A 54-year-old woman with multi-systemic levamisole-induced vasculitis which triggered bilateral cicatrizing conjunctivitis refractory to conventional immunosuppressants due to continued cocaine misuse. Conclusion: Levamisole-induced vasculitis is a significant public health issue due to its popularity as an adulterant to cocaine. Our report suggests that levamisole caused vasculitis and ocular cicatricial pemphigoid in this case. Ocular manifestation of this syndrome is rare.

scholarly journals What Do We Know About and What Could Be the Strategy Adopted to Treat Mucormycosis on Post-COVID-19 Cases? Is It an Adjuvant Nanomaterial?

2021 ◽  
Author(s):  
Gerson Nakazato ◽  
Wagner J Favaro ◽  
Nelson Duran
Keyword(s):  
Public Health ◽  
Fungal Infections ◽  
Specific Treatment ◽  
New Drugs ◽  
Public Health Issue ◽  
Great Effort ◽  
Significant Public Health ◽  
The Usa ◽  
Current Therapies ◽  
Second Wave

Unfortunately, Coronavirus disease 2019 (COVID-19) remains a significant public health issue worldwide, mainly in the USA, India and Brazil. The 2nd wave of COVID-19 has reached India first. The country has been making great effort to stabilize its current condition but, unfortunately, mucormycosis infection (or black fungus) associated with COVID-19 has emerged as another threat to the country and, most likely, to Brazil. It may have happened due to excessive glucocorticoid using, since the widespread administration of this drug can lead to secondary fungal infections. Mucormycosis is generated by a group of molds called mucormycetes; it is a rare, although likely fatal, contamination when patients are not properly treated. The concerning factor lies on the fact that the high COVID-19 incidence recorded in the first wave of it has increased even faster in its second wave in India; there have been some concerning cases in Brazil, as well. The current overview addresses the current therapies used to treat mucormycosis worldwide, as well as potential and new drugs for such a specific treatment. Anti-mucormycosis adjuvants and nanomaterials are the most interesting alternatives to treat patients with post-COVID-19 mucormycosis.

Sign in / Sign up

Export Citation Format

Share Document